Delivery Order SPE2DB20D3505-SPE2DB25FV0N2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $14,787.00. This firm fixed-price delivery order, which is set to be completed by August 12, 2025, will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a competitive procurement with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Eliquis 5 mg tablets (60-count) valued at $14,097.60. This firm fixed-price delivery order is scheduled for completion by August 12, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) valued at $3,484.49. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026. The delivery order carries an ultimate completion date of July...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $14,873.42 under a firm fixed-price contract. This non-set-aside delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements, with performance to be completed by July 21, 2025, and fulfillment from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $18,978.90. This non-set-aside competitive award is scheduled for completion by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $3,271.68 with a firm fixed price structure and an ultimate completion date of August 12, 2025. This is a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), which is valued at $999.999 billion and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units. This $23,630.04 firm fixed price delivery order represents a non-set-aside, competitively awarded contract with a completion date of July 31, 2025. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $13,452.67. This firm fixed-price delivery order is scheduled for completion by July 21, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued without set-aside restrictions, drawing from AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a ceiling value of $9,366.47. This competitive, firm fixed-price delivery order is expected to be completed by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $10,308.12 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This is a firm fixed price, non-set-aside contract with a completion date of July 22, 2025, and performance location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a relatively small transaction within the company's extensive federal pharmaceutical...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FV0N2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract valued at $1,862.57. This competitively awarded, non-set-aside delivery order is scheduled for completion by July 29, 2025, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. Through this prime vendor contract, AmerisourceBergen supplies an extensive portfolio of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies. The DLA Troop Support Medical supply chain leverage allows AmerisourceBergen to serve multiple federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key provider within the federal pharmaceutical procurement ecosystem.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/28/25 |